News

Filter

Current filters:

RebifNeurological

1 to 9 of 11 results

Appeals Court rules against EMD Serono over Rebif deal with Pfizer

16-04-2013

Germany's Merck KGaA (MRK: DE) says that a Pennsylvania appeals court has ruled against Merck in deciding…

BiotechnologyEMD SeronoLegalMarkets & MarketingMerck KGaANeurologicalNorth AmericaPfizerPharmaceuticalRebif

US FDA approves Merck KGaA's Rebif Rebidose

04-01-2013

German drug major Merck KGaA's (MRK: DE) US subsidiary EMD Serono and pharma behemoth Pfizer (NYSE: PFE)…

BiotechnologyEMD SeronoMerck KGaANeurologicalNorth AmericaPfizerPharmaceuticalRebifRegulation

Expanded use for Merck Serono’s Rebif in EU

25-01-2012

Merck Serono, the Switzerland-based division of Germany’s Merck KGaA (MRK: DE), says that that the…

EuropeMerck KGaAMerck SeronoNeurologicalPharmaceuticalRebifRegulation

Genzyme’s MS drug Lemtrada shows significant efficacy versus Rebif

15-11-2011

US biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) says that the Phase…

BayerGenzymeLemtradaNeurologicalPharmaceuticalRebifResearchSanofi

1 to 9 of 11 results

Back to top